Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced their ...

With careful consideration of several factors, many patients can avoid an overnight stay, reducing costs without sacrificing ...

CathVision, a leader in advanced cardiac electrophysiology (EP) technology, is pleased to announce its participation and exhibition at the Heart Rhythm Society (HRS) 2025 Annual Scientific Sessions at ...

Often seen as an option of last resort for ventricular tachycardia, new research suggests catheter ablation could have a ...

A warning to stop using certain Novasight Hybrid diagnostic intravascular catheters was distributed by the FDA. Moderate- and ...

CMC's Cardiac Electrophysiology team pioneers laser-assisted pacemaker lead extraction, enhancing patient outcomes with ...

Anumana announced that it brought its diagnostic ECG-AI technology into perioperative and acute cardiac care with Boston ...

Boston Scientific reports positive outcomes from the ADVANTAGE AF trial’s second phase, assessing the Farapulse and Farapoint systems.

Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month primary endpoint results from the second phase of ...

Boston Scientific’s FARAPULSE system is showing some serious promise in zapping away persistent atrial fibrillation, ...